Specifically, GLP-1a included exenatide (A10BJ01) and liraglutide (A10BJ02), while DPP-4i included sitagliptin (A10BH01), vildagliptin (A10BH02), saxagliptin (A10BH03), alogliptin (A10BH04), and linagliptin (A10BH05)
Formulated for once-weekly administration via a specialized pre-filled pen to ensure consistent dosing and patient compliance
However, it is important to note that degradation may occur without visible changes , so storage history remains the primary determinant of usability
IL-6 signalling exhibits both pro- and anti-inflammatory properties: it initially promotes the differentiation of macrophages and T- and B-lymphocytes, and later contributes to the resolution of inflammation 57
Most users report skin appearing essentially unchanged during this initial two-week window, creating false security that benefits will maintain indefinitely without recognizing that collagen degradation processes haven't yet depleted treatment-induced gains